NDAINTRAVENOUSPOWDER
Approved
Jun 2022
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Pemetrexed ditromethamine is an intravenous powder formulation of pemetrexed, a multitargeted antifolate antimetabolite used in oncology. It is administered intravenously and designed to treat various malignancies by inhibiting multiple folate-dependent enzymes. This represents Pfizer's optimized salt formulation of the established pemetrexed molecule.
Peak
Product is at peak commercial stage for Pfizer's oncology portfolio; commercial teams supporting this asset are likely operating at full capacity with mature market penetration strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on pemetrexed ditromethamine offers stability in a mature, peak-stage oncology asset with established market presence, strong reimbursement infrastructure, and a large patient population. Career growth on this product is primarily through deepening commercial expertise in oncology, competitive positioning, and healthcare economics rather than pioneering new indication development.
Brand Manager
Worked on PEMETREXED DITROMETHAMINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.